Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Neuroimmunology|January 3, 2021
Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disordersTetsuya Akaishi, Tatsuro Misu, Toshiyuki Takahashi, et al.
Journal of Neuroimmunology|February 11, 2014
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosisDouglas Kazutoshi Sato, Ichiro Nakashima, Amit Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 27, 2014
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibodyKensuke Ikeda, Naoki Kiyota, Hiroshi Kuroda, et al.
Research Square|July 3, 2023
Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's diseasePranay Srivastava, Shuhei Nishiyama, Sonia H Lin, et al.
Journal of Neurology|November 25, 2021
Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated diseaseTetsuya Akaishi, Tatsuro Misu, Kazuo Fujihara, et al.
Frontiers in Neurology|March 11, 2021
Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4-Positive Neuromyelitis optica Spectrum DisorderTetsuya Akaishi, Toshiyuki Takahashi, Kazuo Fujihara, et al.
International Journal of Molecular Sciences|May 7, 2025
CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated DiseaseHirohiko Ono, Tatsuro Misu, Chihiro Namatame, et al.
Journal of Neurology|January 8, 2021
Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disordersTetsuya Akaishi, Toshiyuki Takahashi, Kazuo Fujihara, et al.
Multiple Sclerosis and Related Disorders|July 17, 2020
Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosisTetsuya Akaishi, Toshiyuki Takahashi, Kazuo Fujihara, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 19, 2023
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's DiseasePranay Srivastava, Shuhei Nishiyama, Fang Zhou, et al.
Pageof 6